glp-1-directed nmda receptor antagonism for obesity treatment Frontiers PDF) GLP-1-directed NMDA receptor antagonism
Description
You can use the thighs, abdomen, or upper arms
Researchers are investigating the potential of these drugs further
Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al
According to researchers, weight reduction is quicker in the first 6 months, and slows after that, plateauing at 12-18 months
Ovulation becomes irregular
In humans, once-weekly subcutaneous dual GLP-1R/GIPR agonist LY3298176 administration obtained greater weight loss and glucose control than dulaglutide, with an acceptable tolerability profile [166]
